Sharmilan Thanendrarajan Selected Research

Sharmilan Thanendrarajan Research Topics

23	Multiple Myeloma 04/2024 - 01/2016
8	Neoplasms (Cancer) 01/2024 - 09/2011
3	Infections 03/2024 - 07/2023
2	Agammaglobulinemia (Hypogammaglobulinemia) 08/2023 - 07/2023
2	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 02/2016
1	Hyperferritinemia 03/2024
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Anemia 02/2024
1	Immunoglobulin Light-chain Amyloidosis 01/2024
1	Bone Diseases (Bone Disease) 10/2023
1	Lymphopenia (Lymphocytopenia) 08/2023
1	Neutropenia 07/2023
1	Necrosis 07/2023
1	Paraproteinemias (Monoclonal Gammopathy) 11/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022
1	Genetic Translocation (Chromosomal Translocation) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Residual Neoplasm 01/2022
1	Disease Progression 02/2021
1	Smoldering Multiple Myeloma 02/2021
1	Heart Failure 10/2020
1	Pulmonary Hypertension 10/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Dyspnea (Shortness of Breath) 10/2020
1	Carcinogenesis 01/2020
1	Bacteremia 04/2019
1	Amyloidosis 01/2017
1	Atrial Fibrillation 02/2016
1	Lymphoma (Lymphomas) 12/2012

6	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024 - 01/2023
4	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2022
3	Bispecific AntibodiesIBA 08/2023 - 01/2022
3	Monoclonal AntibodiesIBA 01/2022 - 01/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024 - 07/2023
2	B-Cell Maturation AntigenIBA 03/2024 - 01/2024
2	Proteasome InhibitorsIBA 10/2020 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2018
1	Immunoglobulin D (IgD)IBA 04/2024
1	Transferrin (beta 2 Transferrin)IBA 03/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023
1	Thalidomide (Thalomid)FDA Link 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 12/2023
1	Lenalidomide (CC 5013)FDA Link 12/2023
1	Melphalan (Alkeran)FDA LinkGeneric 12/2023
1	Bortezomib (Velcade)FDA Link 12/2023
1	Cystatin MIBA 10/2023
1	NIMA-Related KinasesIBA 10/2023
1	ParaproteinsIBA 07/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	daratumumabIBA 08/2021
1	Cell-Free Nucleic AcidsIBA 02/2021
1	carfilzomibIBA 10/2020
1	Amyloidogenic ProteinsIBA 12/2017
1	Immunomodulating AgentsIBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 12/2012
1	CytokinesIBA 05/2012
1	Cancer VaccinesIBA 09/2011

11	Therapeutics 02/2024 - 01/2016
6	Stem Cell Transplantation 03/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 03/2022 - 01/2016
2	Hematopoietic Stem Cell Transplantation 12/2023 - 02/2016
1	Laparotomy 07/2023
1	Transplantation 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 12/2012
1	Immunotherapy 09/2011